Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.74 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.74 |
| ▸ | FABP3 | P05413 | 9/20 | 0.69 |
| ▸ | FAAH | O00519 | 3/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ricinoleic Acid SCHEMBL3620412 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL34463633 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL9008310 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL18304089 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL15532 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL3620409 | 1.00 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL28488656 | 0.99 | FFAR1 (0.72) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL29154354 | 0.99 | FFAR1 (0.72) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL30366953 | 0.99 | FFAR1 (0.72) | FFAR1FFAR4FABP3FAAHNFKB1 | |
| Ricinoleic Acid SCHEMBL313260 | 0.97 | FFAR1 (0.74) | FFAR1FFAR4FABP3FAAHNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3307232-B1 | USE OF CITRIC ACID ESTERS AS CORROSION INHIBITORS IN ALCOHOLIC COSMETIC COMPOSITIONS SPRAYABLE AS AEROSOLS | HENKEL AG & CO KGAA (DE) | 2020-02-19 | — | — | EP | claimed |
| US-20180140522-A1 | USE OF CITRIC ACID ESTERS AS CORROSION INHIBITOR IN ALCOHOLIC COSMETIC COMPOSITIONS THAT CAN BE SPRAYED AS AN AEROSOL | HENKEL AG & CO. KGAA (DE) | 2018-05-24 | — | — | US | claimed |
| CN-101818104-B | Neutral cleaning agent for bathroom equipment and preparation method thereof | BEIJING LVSAN CHEM CO LTD | 2011-09-28 | — | — | CN | claimed |
| CN-101818104-A | Neutral cleaning agent for bathroom equipment and preparation method thereof | BEIJING LVSAN CHEM CO LTD | 2010-09-01 | — | — | CN | claimed |
| WO-2024242850-A1 | DISSOLVABLE NANOCELLULOSE SHEET | BERKLEY MEDICAL RESOURCES, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240384470-A1 | DISSOLVABLE NANOCELLULOSE SHEET | BERKLEY MEDICAL RESOURCES, INC. (US) | 2024-11-21 | — | — | US | disclosed |
| EP-4464763-A1 | DISSOLVABLE NANOCELLULOSE SHEET | Berkley Medical Resources, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| US-20230390170-A1 | CONSUMER PRODUCTS CONTAINING PRO-FRAGRANCES | FIRMENICH & CIE (CH) | 2023-12-07 | — | — | US | disclosed |
| CN-108135760-A | Biodegradable absorbent article | 托马斯·C·凯里什 | 2018-06-08 | — | — | CN | disclosed |
| US-20180140522-A1 | USE OF CITRIC ACID ESTERS AS CORROSION INHIBITOR IN ALCOHOLIC COSMETIC COMPOSITIONS THAT CAN BE SPRAYED AS AN AEROSOL | HENKEL AG & CO. KGAA (DE) | 2018-05-24 | — | — | US | disclosed |
| CN-107258820-A | A kind of composite disinfectant for animals | 安徽省黄淮兽药有限公司 | 2017-10-20 | — | — | CN | disclosed |
| CN-101818104-B | Neutral cleaning agent for bathroom equipment and preparation method thereof | BEIJING LVSAN CHEM CO LTD | 2011-09-28 | — | — | CN | disclosed |
| EP-2283805-A1 | Compositions comprising a zinc containing compound dissolved in a hydrophobic phase | Sirvis BV (NL) | 2011-02-16 | — | — | EP | disclosed |
| CN-101818104-A | Neutral cleaning agent for bathroom equipment and preparation method thereof | BEIJING LVSAN CHEM CO LTD | 2010-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390170-A1 | CONSUMER PRODUCTS CONTAINING PRO-FRAGRANCES | SCO2, TRPA1, PPOX | FFAR1 528/4885FFAR4 1386/4885FABP3 3113/4885 |
| US-20180140522-A1 | USE OF CITRIC ACID ESTERS AS CORROSION INHIBITOR IN ALCOHOLIC COSMETIC COMPOSITIONS THAT CAN BE SPRAYED AS AN AEROSOL | CS, ADH1C, ADH1A | FFAR1 509/4885FFAR4 1734/4885FABP3 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.